28.08.2024
Finding his path: Anton Medvedev’s journey in Sales and Marketing
In 2015, Anton Medvedev, Business Unit Head at Acino Ukraine, joined the Pharma Start production plant in Kyiv as Product...
Acino
News
24.07.2024
Acino signs an exclusive agreement with LG Chem for Novel Treatments for Type 2 Diabetes and Osteoarthritis in Latin America
M8 Pharmaceuticals, an Acino company (“M8”), today announces the signature of an exclusive licensing and distribution agreement with LG Chem...
26.06.2024
Your partner for innovative medicines in emerging markets
In the recent months, we have strategically expanded our portfolio with several novel products, marking a significant step forward in...
24.06.2024
Acino signs an exclusive licensing and supply agreement with Allecra Therapeutics in Gulf Cooperation Council countries and South Africa
The agreement focuses on the distribution of Allecra’s novel antibiotic drug EXBLIFEP® (cefepime/enmetazobactam) within the Republic of South Africa and...
17.06.2024
Acino in Ukraine Achieves GDP Certification
For the first time, Acino in Ukraine has received the Certificate of Good Distribution Practice (GDP). Following a rigorous inspection...
13.06.2024
A family introduction: The Urso Russos love the work environment at Acino
Father Giuseppe and his sons Michele and Filippo joined Acino’s bulk production site as production operators in Liesberg in 2022...
15.05.2024
From Junior to Leader: Patrick Frey’s rapid ascent at Acino
Patrick Frey rose within just six years from a junior position in Out-Licensing to Head of B2B at Acino. Here...
07.05.2024
Acino signs an exclusive license agreement with Supernus in Latin America
M8 Pharmaceuticals, an Acino company (‘M8’) announces that the company has signed an exclusive licensing agreement with Supernus Pharmaceuticals, Inc....
29.04.2024
Acino tops the list of best employers in the Ukrainian pharmaceutical sector
Acino has been recognised as the top employer among pharmaceutical companies in Ukraine. This ranking is the result of a...